Current Share price could increase due to investor excitment:
- PAR received Therapeutic Goods Administration (TGA) provisional approval on 25th October 2019 = Possible revenue generation next year
- PAR expects to meet FDA approval requirements within 2019
- PAR is expected to treat 10 ex-US NFL patients within Q1 of 2020 with Zilosul drug = efficacy evidence
- These exciting and revenue provoking events could see current price rise higher
Current Share price could increase due to investor excitment: -...
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.5¢ |
Change
-0.030(10.9%) |
Mkt cap ! $85.7M | |||
| Open | High | Low | Value | Volume |
| 27.5¢ | 27.5¢ | 24.0¢ | $429.9K | 1.713M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 161991 | 24.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.5¢ | 29634 | 2 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
25.0¢ |
Change
-0.030 ( 7.51 %) |
||||
| Open | High | Low | Volume | ||
| 27.0¢ | 27.0¢ | 23.5¢ | 433775 | ||
| Last updated 15.57pm 03/05/2024 ? | |||||
| PAR (ASX) Chart |